The pathogenesis of HS involves immune dysregulation, with elevated levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-17 (IL-17) [3,4,5]. This evidence concerns the gene IL17A and histiocytic sarcoma.